MORE VIDEOS
Explore more

Head and Neck Cancer

Head & Neck Cancers CME Series:
Head & Neck Cancers CME Series: administrator 1 Views • 2 years ago

November 9, 2022
Hosted by: Saral Mehra, MD
Presentations by:
Aarti Bhatia, MD, MPH: Immunotherapy and Anti-Angiogenic Therapies
Jeffrey Ishizuka, MD, DPhil: New Research and Tumor Hypoxia
Navid Hafez, MD, MPH: Novel Targets in Phase 1 Trials
Treatment for HPV-related Head and Neck Cancer - Mayo Clinic
Treatment for HPV-related Head and Neck Cancer - Mayo Clinic administrator 0 Views • 2 years ago

Mayo Clinic head and neck cancer specialists are looking at ways to decrease how intense the treatment is for patients who have HPV-related head and neck cancer. Patients can do very well with limited minimally invasive surgery and a decreased dose of targeted radiotherapy and sometimes targeted chemotherapy, resulting in much fewer side effects from those treatments. To learn more about head and neck cancer care at Mayo Clinic, visit: https://mayocl.in/33GmsG9

Head & Neck Cancer Diagnosis
Head & Neck Cancer Diagnosis administrator 1 Views • 2 years ago

KNOW THE SIGNS: Head and Neck Cancers | DOTV
KNOW THE SIGNS: Head and Neck Cancers | DOTV administrator 4 Views • 2 years ago

Head and neck cancers can be frightening because of their critical location, but they are very treatable, especially when found in early stages. Know the signs and have a better chance of being cured.

Guest:
Dr. Gil M. Vicente
Otolaryngologist | Head and Neck Surgeon

Host:
Dr. Sarah Barba-Cabodil




Subscribe to our official YouTube channel, https://bit.ly/2ImmXOi

Be the first to know about the latest updates on COVID-19 pandemic, lockdowns, community quarantine, new normal, and Serbisyong Bayanihan.

We Serve the People. We Give Glory To God!
#SerbisyongBayanihan #UNTVNewsandRescue

For updates, visit: https://www.untvweb.com/news/

Check out our official social media accounts:
https://www.facebook.com/UNTVNewsRescue
https://www.twitter.com/untvnewsrescue
https://www.youtube.com/untvnewsandrescue
Instagram account - @untvnewsrescue

Feel free to share but do not re-upload.

Clinical Trial: Squamous Cell Cancers of the Head & Neck - Robert Chin, MD | UCLA Radiation Onco
Clinical Trial: Squamous Cell Cancers of the Head & Neck - Robert Chin, MD | UCLA Radiation Onco administrator 0 Views • 2 years ago

#UCLARadOnc
UCLA Health is looking for patients with newly diagnosed HPV+ cancers of the head and neck for a new clinical trial looking at ways to reduce toxicity in treatment of HPV associated tumors. Existing treatments for HPV+ head and neck cancers are excessively toxic. We are pioneering a radically new approach as part of our clinical trial. Come join our study. Call us at (310) 267-8991 for a consultation with UCLA Radiation Oncology, or visit https://ucla.in/3gAT9t1 and click “I’m Interested” to learn more.

HPV-related Head and Neck Cancer - Mayo Clinic
HPV-related Head and Neck Cancer - Mayo Clinic administrator 0 Views • 2 years ago

Human Papilloma Virus (HPV) related oropharynx cancers are now the 8th leading cancer in men in the U.S. HPV-induced tumors hit a very healthy young patient population. Although on the rise, 99% of the people with HPV-tumors are cured by treatment. Patients can do very well with limited minimally invasive surgery and a decreased dose of targeted radiotherapy and sometimes targeted chemotherapy, resulting in much fewer side effects from those treatments. Learn more about head and neck cancer care at Mayo Clinic: https://mayocl.in/33GmsG9

ESMO 2022 highlights in head and neck cancer
ESMO 2022 highlights in head and neck cancer administrator 1 Views • 2 years ago

Jean-Pascal Machiels, MD, PhD, Cliniques Universitaires Saint-Luc, Brussels, Belgium, discusses key highlights in head and neck cancer from the European Society for Medical Oncology (ESMO) 2022 Congress. A phase II study (NCT03692325) of nivolumab for high-risk oral leukoplakia, an aggressive precancerous disease characterized by multifocal lesions and a high-risk of transformation to oral squamous cell carcinoma (OSCC). The primary outcome was best overall response rate and secondary endpoints included cancer-free survival (CFS) and overall-survival (OS). Nivolumab yielded a best response of proliferative leukoplakia regression among 37% of patients with a favorable overall CFS. Additionally, a Phase II trial (NCT02022098) demonstrated a 5-year OS benefit in patients with locally advanced squamous cell carcinoma of the head and neck (LA SCCHN) treated with xevinapant plus chemoradiotherapy compared to placebo plus chemoradiotherapy. The five-year results from the Phase III KEYNOTE-048 (NCT02358031) investigating pembrolizumab with or without chemotherapy for first-line treatment of recurrent/metastatic head and neck squamous cell carcinoma (HNSCC) showed durable antitumor activity and manageable safety. This interview took place at the European Society for Medical Oncology (ESMO) 2022 Congress in Paris, France.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Proton therapy side effects in head and neck cancer patients
Proton therapy side effects in head and neck cancer patients administrator 1 Views • 2 years ago

What are the common side effects for head and neck cancer patients being treated with proton therapy? MD Anderson outpatient clinical nurse Kenan Oren explains the side effects and offers recommendations for coping with them.

Request an appointment at MD Anderson by calling 1-877-632-6789 or online: my.mdanderson.org/requestappointment
Head and Neck Cancer: Causes, Symptoms & Treatment | Dr. Deepanshu Gurnani ( Hindi )
Head and Neck Cancer: Causes, Symptoms & Treatment | Dr. Deepanshu Gurnani ( Hindi ) administrator 1 Views • 2 years ago

Head and neck cancer is one of the most significant reasons for the morbidity in Indian males also it is the second most common cancer among women. Tobacco, smoking, alcohol consumption, and sometime toxin exposure causes head and neck cancer. As the symptoms are pretty common, most of the people don't treat it, and that increases the intensity of cancer.

Dr. Deepanshu Gurnani, Consultant - ENT, Head and Neck Surgery at Narayana Multispeciality Hospital, Jaipur, explains the causes, symptoms, and treatment of head and neck cancer. According to the doctor, Stage one diagnosis provides us with a 95% survival rate.

#NarayanaHealth #HealthForAll #AllForHealth #NHCares

For video consultation with the doctor, log on to https://video.narayana.health/home

Visit our website https://www.narayanahealth.org to know more about Narayana Health and its facilities.

Connect with us:
Facebook - https://www.facebook.com/NarayanaHealth/
Instagram - https://www.instagram.com/narayanahealthindia/
Twitter - https://twitter.com/narayanahealth
Blog - https://www.narayanahealth.org/blog/
LinkedIn - https://www.linkedin.com/company/narayanahealth

Head and Neck Cancer Treatment: Better Outcomes, Better Function
Head and Neck Cancer Treatment: Better Outcomes, Better Function administrator 0 Views • 2 years ago

While many different head and neck cancers fall under the same category, they all greatly differ in how symptoms present. UChicago Medicine otolaryngologist Dr. Nishant Agrawal and oncologist Dr. Ari Rosenberg share what you need to know about head and neck cancers. From early detection and symptoms to treatment options and clinical trials, our experts answer the questions you want to know.
Showing 52 out of 53